~~<i id='DD55C4F662'><strike id='DD55C4F662'><tt id='DD55C4F662'><pre id='DD55C4F662'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：Wikipedia 2025-09-29 20:52:24 - browse：739

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Readout Newsletter: Merck, Vertex, and Viking updates

knowledge

focus

explore

focus

hotspot

Fromleft,STAT'sAllisonDeAngelis,ALSadvocateCathyCollet,Yale'sGreggGonsalves,SickCells'AshleyValentin

WSS

Moderna says combo Covid

Why the world’s most expensive drug might be worth the price

STAT Virtual Event: ASCO Recap, Live!

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Teladoc has a new CEO, but challenges remain the same

How faith leaders like me can help address America's obesity epidemic

focus

entertainment

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck drug for rare lung condition set for approval in U.S.

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: mifepristone case, GLP

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Eliminate the waiting period for sterilization covered by Medicaid

New air purifier tech could be key to improving indoor air quality

Readers discuss the intersection of pregnancy and addiction

How one medical school became remarkably diverse

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

focus

Primary care physicians play key roles in Alzheimer's management

My daughter's legacy lives on through her writing, phage therapy

'Essentially witchcraft:' A former naturopath takes on the field

Food as medicine: Medically tailored meals may get standardized

FDA's naming rule on biosimilars has undermined competition

'Essentially witchcraft:' A former naturopath takes on the field

explore

focus

focus

hotspot